- Home
- ATKR vs XENE Comparison
ATKR vs XENE Comparison
Compare ATKR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATKR
- XENE
- Stock Information
- Founded
- ATKR 1959
- XENE 1996
- Country
- ATKR United States
- XENE Canada
- Employees
- ATKR N/A
- XENE N/A
- Industry
- ATKR Industrial Machinery/Components
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- ATKR Miscellaneous
- XENE Health Care
- Exchange
- ATKR Nasdaq
- XENE Nasdaq
- Market Cap
- ATKR 2.2B
- XENE 2.4B
- IPO Year
- ATKR 2016
- XENE 2014
- Fundamental
- Price
- ATKR $78.51
- XENE $31.01
- Analyst Decision
- ATKR Buy
- XENE Strong Buy
- Analyst Count
- ATKR 6
- XENE 11
- Target Price
- ATKR $79.83
- XENE $54.82
- AVG Volume (30 Days)
- ATKR 503.0K
- XENE 1.5M
- Earning Date
- ATKR 08-05-2025
- XENE 08-07-2025
- Dividend Yield
- ATKR 1.68%
- XENE N/A
- EPS Growth
- ATKR N/A
- XENE N/A
- EPS
- ATKR 5.38
- XENE N/A
- Revenue
- ATKR $2,973,983,000.00
- XENE $7,500,000.00
- Revenue This Year
- ATKR N/A
- XENE N/A
- Revenue Next Year
- ATKR $1.95
- XENE $253.71
- P/E Ratio
- ATKR $14.61
- XENE N/A
- Revenue Growth
- ATKR N/A
- XENE N/A
- 52 Week Low
- ATKR $49.92
- XENE $26.74
- 52 Week High
- ATKR $140.99
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- ATKR 67.14
- XENE 43.52
- Support Level
- ATKR $72.80
- XENE $30.84
- Resistance Level
- ATKR $75.50
- XENE $32.72
- Average True Range (ATR)
- ATKR 2.22
- XENE 1.10
- MACD
- ATKR 0.17
- XENE -0.14
- Stochastic Oscillator
- ATKR 83.89
- XENE 6.54
About ATKR Atkore Inc.
Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.